Key facts
- This page summarizes Andrew A. F. Hack's Form 4 filing for DYNAVAX TECHNOLOGIES CORP (DVAX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Aug 2023, 16:31.
Andrew A. F. Hack - 08 Aug 2023 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)
- Reporting relationship
- Director
- Issuer ticker
- DVAX
- Reported as of
- 08 Aug 2023
- Net transaction value
- -$21,585,000
- SEC form
- 4
- Accepted by SEC
- 10 Aug 2023, 16:31:14 UTC
- Prior SEC filing
- 16 Jun 2023
- Next SEC filing
- 29 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew Hack
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew A. F. Hack filed Form 4 for DYNAVAX TECHNOLOGIES CORP (DVAX) on 10 Aug 2023.
Change
- Previous filing in this sequence was filed on 16 Jun 2023.
- Current net transaction value: -$21,585,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DVAX
transaction
Common Stock
Sale
- Transaction value
- $21,585,000
- Shares
- -1,500,000
- Change %
- -62%
- Price
- $14.39
- Shares after
- 915,000
- Date
- 08 Aug 2023
- Ownership
- See footnotes
- Footnotes
- F1, F2
DVAX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,714
- Date
- 08 Aug 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares of common stock held directly by Bain Capital Life Sciences Fund, L.P. ("BCLS") and BCIP Life Sciences Associates, LP ("BCIPLS" and, together with BCLS, the "Bain Capital Life Sciences Entities").
Footnote F2
Bain Capital Life Sciences Investors, LLC ("BCLSI") is the ultimate general partner of BCLS and governs the investment strategy and decision-making process with respect to investments held by BCIPLS. Dr. Hack is a Partner of BCLSI. By virtue of the relationships described in this footnote, Dr. Hack may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. Dr. Hack disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.